Research article · 25 Aug 2026
Conference abstractPublished 9 Nov 2017
The potential molecular targets of Fangchinoline for cancer therapy
Yong Loo Lin School of Medicine, National University of Singapore, Singapore
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background: Fangchinoline, a traditional Chinese medicine, is a bis-benzylisoquinoline alkaloid isolated from the dried root of Stephaniae tetrandrine S. Moore (family-Menispermaceae). It has been extensively used as an analgesic, anti-rheumatic and antihypertensive drug, possesses profound pharmacological activities and has gained a lot of interest due to its anti-cancer activity. Aim: This project aimed to investigate the potential anti-cancer effects of Fangchinoline in tumor cells and to identify the molecular targets underlying its mechanisms of action. Methods: The hepatocellular carcinoma cells and breast cancer cells were chosen to assess the effects of Fangchinoline on the cellular cytotoxicity, cell cycle progression, apoptosis and the migratory and invasive potential of these cells by MTT assay, flow cytometry, western blotting, wound healing assay and the invasion assay, respectively. Results: Fangchinoline showed significant cytotoxic effects on Huh-7 and MDA MB-231 cell lines. It arrested these cells at the sub-G1 phase of the cell cycle, induced significant apoptosis in both the tumor cells as evidenced by the activation of procaspase-3, the cleavage of PARP and downregulation of Bcl-2. Additionally, it also attenuated the migratory and invasive potential of both the cell lines significantly. The suppression of the phosphorylated AKT protein level was also observed upon the drug treatment. Conclusion: Overall, the preliminarily results shows that Fangchinoline exerts significant anti-cancer effects on the tumor cells predominantly via the inhibition of the AKT signaling cascade.
Subjects
BiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Current Synthetic and Systems Biology.
Commentary · 30 Dec 2025
Synthetic Organelles Driving Innovation in Biotechnology and
Opinion · 30 Dec 2025
XNAs And The Evolution Of Synthetic Genetic Design
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCurrent Synthetic and Systems Biology
- SubjectBiology
- BylineArticles whose byline prints “Srishti Mishra”
